Aadi Bioscience, Inc.
Aadi Bioscience, Inc. (AADI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AADI · as of Jun 9, 2026
Key Statistics
Explore Aadi Bioscience, Inc. Data
aadi stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
The AADI analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $1.63, representing -20.49% downside from the current price of $2.05.
Competitors & Peers
aadi competitorsAADI
ASXC
BLI
HLVX
IGMS
IMDXStock Performance
Full HistoryAbout Aadi Bioscience, Inc.
Aadi Bioscience, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing highly targeted therapies for cancers defined by specific genetic alterations within the…
what is aadi bioscience, inc. · aadi stock overview · aadi bioscience, inc. company profile · who is aadi bioscience, inc. ceo · aadi NASDAQ · aadi bioscience, inc. headquarters · aadi bioscience, inc. business segments
About Stock Overview & Key Data
Aadi Bioscience, Inc. (AADI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 16, 2018. As of the latest trading session, AADI stock price is $2.05, with a market capitalization of $94.9M. The stock has returned +12.64% over the past 12 months and -34.71% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Aadi Bioscience, Inc. stock is Buy, with an average 12-month price target of $1.63. In fiscal year 2025, Aadi Bioscience, Inc. reported revenue of $7.1M and net income of -$20.6M. For detailed data — including Aadi Bioscience, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aadi Bioscience, Inc. (AADI) stock price is $2.05. The stock is traded on NASDAQ under the ticker symbol AADI. The 52-week range is $1.21 – $3.81.